• Palonosetron Hydrochloride in Preventing Chemotherapy-Induce

  2026-04-13

  This article reviews the pivotal findings from Ruhlmann & Herrstedt’s study on palonosetron hydrochloride for preventing chemotherapy-induced nausea and vomiting (CINV). The paper’s comparative analysis of palonosetron with other 5-HT3 receptor antagonists highlights its unique pharmacology and clinical benefits for both acute and delayed CINV, with implications for optimizing supportive care in oncology settings.

• MPC-Regulated Lactate Induces Histone Lactylation in Tumor I

  2026-04-13

  This study uncovers how mitochondrial pyruvate carrier (MPC) downregulation in colorectal cancer elevates lactate production, driving histone lactylation in dendritic cells and impairing antitumor immunity. The findings highlight metabolic-epigenetic crosstalk as a modifiable axis for optimizing immunotherapy.

• Disrupting 14-3-3:BAD Interactions for Colorectal Cancer The

  2026-04-12

  This study introduces a high-throughput screening strategy to identify FDA-approved drugs that disrupt 14-3-3 protein and BAD interactions, revealing new candidates for colorectal cancer therapy. The approach demonstrates the feasibility of drug repositioning to target apoptosis pathways with translational potential.

• AP20187 as a Precision Tool for Regulating 14-3-3 Pathways

  2026-04-12

  Discover how AP20187, a leading chemical inducer of dimerization, enables unprecedented precision in modulating 14-3-3 protein signaling and autophagy regulation. This article explores advanced applications and protocol insights not covered in previous reviews.

• Dual Luciferase Reporter Gene System: Precision in BCa Resea

  2026-04-11

  Harness the Dual Luciferase Reporter Gene System for high-throughput, accurate transcriptional regulation studies in cancer biology. APExBIO's kit streamlines workflows and delivers robust normalization, empowering researchers to dissect signaling pathways such as Wnt/β-catenin with clarity and reproducibility.

• AO/PI Double Staining Kit: Precision in Cell Viability Assay

  2026-04-11

  The AO/PI Double Staining Kit empowers researchers to rapidly and distinctly quantify viable, apoptotic, and necrotic cells in complex biological models. Its dual-fluorescence approach streamlines apoptosis and necrosis detection, offering actionable insights for experimental workflows and troubleshooting in translational and basic research.

• Mestranol (3-Methyl Ether of Ethinylestradiol): Lab Use Guid

  2026-04-10

  Mestranol is a synthetic estrogen prodrug used primarily in research on estrogen metabolism, contraceptive mechanisms, and prodrug activation. It is not suitable for diagnostic or medical applications and should not be used outside controlled laboratory workflows.

• LGK-974 and the Next Frontier of Wnt Pathway Inhibition: ...

  2026-04-10

  This thought-leadership article dissects the mechanistic underpinnings and translational promise of LGK-974 (Porcupine Inhibitor), a potent and specific Wnt signaling pathway inhibitor. We explore the biological rationale for targeting PORCN in Wnt-driven cancers, validate LGK-974’s efficacy in preclinical models, position it within the evolving competitive landscape, and provide actionable strategic guidance for translational researchers aiming for next-generation breakthroughs in cancer therapy.

• 3-Aminobenzamide (PARP-IN-1): Potent PARP Inhibitor for A...

  2026-04-09

  3-Aminobenzamide (PARP-IN-1) is a potent poly (ADP-ribose) polymerase inhibitor with nanomolar IC50, enabling precise PARP activity inhibition assays in CHO cells and disease models. This article details mechanistic rationale, evidence benchmarks, and practical workflow integration for oxidative stress and diabetic nephropathy research.

• DiscoveryProbe™ FDA-approved Drug Library: Advanced Insig...

  2026-04-08

  Explore how the DiscoveryProbe FDA-approved Drug Library empowers next-generation high-throughput screening, drug repositioning, and mechanistic target identification. This article delivers original scientific analysis and application strategies beyond standard workflows.

• Balsalazide Disodium Dihydrate: Precision Tools for Infla...

  2026-04-08

  Balsalazide Disodium Dihydrate redefines inflammation research with its colon-targeted activation, robust water solubility, and advanced modulation of cytokine and immune pathways. Its unique prodrug mechanism and radiolabeling compatibility empower reproducible workflows in ulcerative colitis and immunology models. Discover how APExBIO’s high-purity offering sets a new standard for experimental rigor and translational insight.

• Optimizing Wnt Pathway Studies with LGK-974 (Porcupine In...

  2026-04-07

  This article provides a scenario-driven guide to employing LGK-974 (Porcupine Inhibitor, SKU B2307) for reproducible Wnt signaling pathway inhibition in cancer and developmental biology research. Drawing on validated protocols and comparative analysis, it addresses real-world bench challenges and demonstrates how LGK-974 ensures reliable assay outcomes. Researchers will discover practical strategies for experimental design, interpretation, and vendor selection, all supported by quantitative data and peer-reviewed evidence.

• Balsalazide Disodium Dihydrate: Advanced Research Applica...

  2026-04-06

  Balsalazide Disodium Dihydrate stands out as a water-soluble anti-inflammatory compound that enables precision research in ulcerative colitis and cytokine signaling. By leveraging its prodrug mechanism and robust radiolabeling compatibility, researchers can optimize IBD models, in vitro assays, and imaging workflows with reproducible, high-sensitivity results.

• Dual Luciferase Assay System: Precision Gene Expression A...

  2026-04-06

  APExBIO's Dual Luciferase Assay System empowers researchers to unlock high-throughput, quantitative gene expression regulation studies with unrivaled sensitivity. Its streamlined, cell-lysis-free workflow and dual-reporter normalization set a new benchmark for bioluminescence reporter assays in mammalian cells.

• Scenario-Driven Solutions with Balsalazide Disodium Dihyd...

  2026-04-05

  This authoritative guide addresses practical challenges in cell viability, proliferation, and cytotoxicity assays by applying Balsalazide Disodium Dihydrate (SKU C6459) as a reproducible, water-soluble anti-inflammatory agent. We draw on validated protocols and peer-reviewed data to help researchers optimize workflows, interpret results, and select reliable vendors for inflammation and IBD research.

16119 records 1/1075 page Next 12345 下5页 Last page